TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Entero Therapeutics ( (ENTO) ) just unveiled an announcement.
Entero Therapeutics, Inc. received a letter from Nasdaq on April 11, 2025, indicating non-compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market. The company was granted an extension until October 8, 2025, to regain compliance, which it achieved through a share exchange agreement with GridAI Corp. Nasdaq confirmed compliance on October 28, 2025, but warned that failure to maintain compliance in future reports could lead to delisting.
More about Entero Therapeutics
Average Trading Volume: 1,820,830
Technical Sentiment Signal: Hold
Current Market Cap: $7.04M
Learn more about ENTO stock on TipRanks’ Stock Analysis page.